Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3360 Target Snapshot

Adenosine receptor A3 · SINGLE PROTEIN · Rattus norvegicus

587Compounds
134Assays
3Approved Drugs
661.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P28647. Use UniProt P28647 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P28647 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Adenosine receptor A3 as ChEMBL target CHEMBL3360, mapped to UniProt P28647. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Adenosine receptor A3
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL3360
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P28647
Adenosine receptor A3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Adenosine receptor A3 is the right protein anchor across sources, using UniProt P28647 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAdenosine receptor A3
UniProt AccessionP28647
Component TypeProtein
Sequence Length320 aa

Adenosine receptor A3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Adenosine receptor A3, mapped to UniProt P28647. Sequence length is 320 aa.

Mapped IDP28647
Review nameAdenosine receptor A3
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

3
Approved
2
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC501.0
KI654.0
EC503.0
KD3.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL27376 9.77 Kd 0.17 Preclinical
CHEMBL431733 9.48 Ki 0.33 Clinical
CHEMBL608327 9.48 Ki 0.33 Preclinical
CHEMBL2113400 9.48 Ki 0.33 Preclinical
CHEMBL200732 9.42 Ki 0.38 Preclinical
CHEMBL2368455 9.12 Ki 0.76 Preclinical
CHEMBL2112157 9.06 Ki 0.87 Preclinical
CHEMBL2113613 9.06 Ki 0.88 Preclinical
CHEMBL175543 9.0 Ki 1.0 Preclinical
CHEMBL133566 9.0 Kd 1.0 Preclinical
Distribution

pChEMBL Value Distribution

47
5.0
46
5.5
71
6.0
82
6.5
55
7.0
44
7.5
32
8.0
40
8.5
20
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

ADENOSINE
CHEMBL477
Approved 1989
Assay Landscape

Assay Landscape

134
Total Assays
411
Tested Compounds
2
Assay Types
Binding — 120 assays, 411 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 64 270 6.7
single protein format 31 54 7.3
assay format 15 59 5.9
cell membrane format 8 28 6.3
tissue-based format 2 0
Functional — 14 assays, 5 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 10 1 7.1
assay format 3 4 4.8
tissue-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine